Publications

Targeting GPX4 palmitoylation to boost antitumor immunity. Hwang D, Henry WS. 2025. Trends Cancer.
doi: 10.1016/j.trecan.2025.05.001
PMID:40374398

ALDH7A1 protects against ferroptosis by generating membrane NADH and regulating FSP1. Yang JS, Morris AJ, Kamizaki K, Chen J, Stark J, Oldham WM, Nakamura T, Mishima E, Loscalzo J, Minami Y, Conrad M, Henry WS, Hsu VW. 2025. Cell.
doi: 10.1016/j.cell.2025.03.019
PMID: 40233740

Advancing cancer research. Taabazuing CY, Henry WS, Oliphant MUJ, Lawrence SS. 2024. Trends Pharmacol Sci 45, 943-949.
doi: 10.1016/j.tips.2024.10.004
PMID: 39477739

Zeb1 mediates EMT/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition. Schwab A, Rao Z, Zhang J, Gollowitzer A, Siebenkäs K, Bindel N, D'Avanzo E, van Roey R, Hajjaj Y, Özel E, Armstark I, Bereuter L, Su F, Grander J, Bonyadi Rad E, Groenewoud A, Engel FB, Bell GW, Henry WS, Angeli JPF, Stemmler MP, Brabletz S, Koeberle A, Brabletz T. 2024. Nat Cell Biol. Epub ahead of print.
doi: 10.1038/s41556-024-01464-1
PMID: 39009641

ATF3 characterizes aggressive drug-tolerant persister cells in HGSOC. Böpple K, Oren Y, Henry WS, Dong M, Weller S, Thiel J, Kleih M, Gaißler A, Zipperer D, Kopp HG et al.. 2024. Cell Death Dis 15, 290.
doi: 10.1038/s41419-024-06674-x
PMID: 38658567

Lipidomes define immune cell identity. Levental KR, Henry WS. 2024. Nat Cell Biol 26, 516-518.
doi: 10.1038/s41556-024-01398-8
PMID: 38589530

Ether lipids influence cancer cell fate by modulating iron uptake. Henry WS, Müller S, Yang JS, Innes-Gold S, Das S, Reinhardt F, Sigmund K, Phadnis VV, Wan Z, Eaton E et al.. 2024. bioRxiv.
doi: 10.1101/2024.03.20.585922
PMID: 38562716

MMD collaborates with ACSL4 and MBOAT7 to promote polyunsaturated phosphatidylinositol remodeling and susceptibility to ferroptosis. Phadnis VV, Snider J, Varadharajan V, Ramachandiran I, Deik AA, Lai ZW, Kunchok T, Eaton EN, Sebastiany C, Lyakisheva A, Vaccaro KD, Allen J, Yao Z, Wong V, Geng B, Weiskopf K, Clish CB, Brown JM, Stagljar I, Weinberg RA, Henry WS. 2023. Cell Rep 42, 113023.
doi: 10.1016/j.celrep.2023.113023
PMID: 37691145

Plasticity of ether lipids promotes ferroptosis susceptibility and evasion. Zou Y*, Henry WS*, Ricq EL*, Graham ET, Phadnis VV, Maretich P, Paradkar S, Boehnke N, Deik AA, Reinhardt F et al.. 2020. Nature 585, 603-608. *These authors contributed equally to this work.
doi: 10.1038/s41586-020-2732-8
PMID: 32939090

Pentraxin-3 is a PI3K signaling target that promotes stem cell-like traits in basal-like breast cancers. Thomas C, Henry W, Cuiffo BG, Collmann AY, Marangoni E, Benhamo V, Bhasin MK, Fan C, Fuhrmann L, Baldwin AS et al.. 2017. Sci Signal 10.
doi: 10.1126/scisignal.aah4674
PMID: 28223411

Aspirin Suppresses Growth in PI3K-Mutant Breast Cancer by Activating AMPK and Inhibiting mTORC1 Signaling. Henry WS, Laszewski T, Tsang T, Beca F, Beck AH, McAllister SS, Toker A. 2017. Cancer Res 77, 790-801.
doi: 10.1158/0008-5472.CAN-16-2400
PMID: 27940576

LINC00520 is induced by Src, STAT3, and PI3K and plays a functional role in breast cancer. Henry WS, Hendrickson DG, Beca F, Glass B, Lindahl-Allen M, He L, Ji Z, Struhl K, Beck AH, Rinn JL et al.. 2016. Oncotarget 7, 81981-81994.
doi: 10.18632/oncotarget.11962
PMID: 27626181

NFAT1 promotes intratumoral neutrophil infiltration by regulating IL8 expression in breast cancer. Kaunisto A, Henry WS, Montaser-Kouhsari L, Jaminet SC, Oh EY, Zhao L, Luo HR, Beck AH, Toker A. 2015. Mol Oncol 9, 1140-54.
doi: 10.1016/j.molonc.2015.02.004
PMID: 25735562